Global gene expression analysis in time series following N-acetyl L-cysteine induced epithelial differentiation of human normal and cancer cells in vitro

BMC Cancer

Volumn 5, Issue , 2005, Pages

  Gustafsson, Anna C ^a   Kupershmidt, Ilya ^a,b   Edlundh Rose, Esther ^a   Greco, Giulia ^c   Serafino, Annalucia ^c   Krasnowska, Eva K ^c   Lundeberg, Thomas ^d   Bracci Laudiero, Luisa ^e   Romano, Mari Concetta ^e   Parasassi, Tiziana ^c   Lundeberg, Joakim ^a  

^a ALBANOVA UNIVERSITY CENTER   (Sweden)

^b Silicon Genetics   (United States)

^c CNR   (Italy)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^e Associazione Italiana Iniziativa Medicina Sociale   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ANTIOXIDANT; CADHERIN;

ANIMAL CELL; ARTICLE; CANCER CELL; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL STRAIN CACO 2; CELL TYPE; COMPUTER PROGRAM; CONTROLLED STUDY; DNA MICROARRAY; DOWN REGULATION; DRUG MECHANISM; EPITHELIUM; GENE ACTIVATION; GENE CONTROL; GENE EXPRESSION; GENE IDENTIFICATION; GENE REPRESSION; GENE SEQUENCE; GENETIC TRANSCRIPTION; GROWTH INHIBITION; HUMAN; HUMAN CELL; IN VITRO STUDY; KERATINOCYTE; NONHUMAN; NUCLEOTIDE SEQUENCE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TIME SERIES ANALYSIS; VALIDATION PROCESS; CELL LINE; CELL LINEAGE; CHEMISTRY; CYTOLOGY; CYTOSKELETON; DRUG EFFECT; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMAN GENOME; KINETICS; METABOLISM; PATHOLOGY; POLYMERASE CHAIN REACTION; SKIN TUMOR; TIME; TUMOR CELL LINE; UPREGULATION;

ACETYLCYSTEINE; ANTIOXIDANTS; CADHERINS; CELL DIFFERENTIATION; CELL LINE; CELL LINE, TUMOR; CELL LINEAGE; CELL PROLIFERATION; CYTOSKELETON; DOWN-REGULATION; EPITHELIUM; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENOME, HUMAN; HUMANS; KERATINOCYTES; KINETICS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYMERASE CHAIN REACTION; SKIN NEOPLASMS; TIME FACTORS; TRANSCRIPTION, GENETIC; UP-REGULATION;

EID: 26844509194     PISSN: 14712407     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-5-75     Document Type: Article

References (76)

1. Parasassi T, Brunelli R, Bracci-Laudiero L, Greco G, Gustafsson AC, Krasnowska EK, Lundeberg J, Lundeberg T, Pittaluga E, Romano MC, Serafino A: Differentiation of normal and cancer cells induced by sulfhydryl reduction: biochemical and molecular mechanisms. Cell Death Differ 2005.
2. Delie F, Rubas W: A human colonic cell line sharing similarities with enterocytes as a model to examine oral absorption: advantages and limitations of the Caco-2 model. Crit Rev Ther Drug Carrier Syst 1997, 14:221-286.
3. Hosack DA, Dennis G Jr, Sherman BT, Lane HC, Lempicki RA: Identifying biological themes within lists of genes with EASE. Genome Biol 2003, 4:R70.
4. De Flora S, Izzotti A, D'Agostini F, Balansky RM: Mechanisms of N-acetylcysteine in the prevention of DNA damage and cancer, with special reference to smoking-related end-points. Carcinogenesis 2001, 22:999-1013.
5. Rosati E, Sabatini R, Ayroldi E, Tabilio A, Bartoli A, Bruscoli S, Simoncelli C, Rossi R, Marconi P: Apoptosis of human primary B lymphocytes is inhibited by N-acetyl-L-cysteine. J Leukoc Biol 2004, 76:152-161.
6. Hart AM, Terenghi G, Kellerth JO, Wiberg M: Sensory neuroprotection, mitochondrial preservation, and therapeutic potential of n-acetyl-cysteine after nerve injury. Neuroscience 2004, 125:91-101.
7. Rhoden CR, Lawrence J, Godleski JJ, Gonzalez-Flecha B: N-acetylcysteine prevents lung inflammation after short-term inhalation exposure to concentrated ambient particles. Toxicol Sci 2004, 79:296-303.
8. Estensen RD, Levy M, Klopp SJ, Galbraith AR, Mandel JS, Blomquist JA, Wattenberg LW: N-acetylcysteine suppression of the proliferative index in the colon of patients with previous adenomatous colonic polyps. Cancer Lett 1999, 147:109-114.
9. Tadjali M, Seidelin JB, Olsen J, Troelsen JT: Transcriptome changes during intestinal cell differentiation. Biochim Biophys Acta 2002, 1589:160-167.
10. Mariadason JM, Arango D, Corner GA, Aranes MJ, Hotchkiss KA, Yang W, Augenlicht LH: A gene expression profile that defines colon cell maturation in vitro. Cancer Res 2002, 62:4791-4804.
11. Fleet JC, Wang L, Vitek O, Craig BA, Edenberg HJ: Gene expression profiling of Caco-2 BBe cells suggests a role for specific signaling pathways during intestinal differentiation. Physiol Genomics 2003, 13:57-68.
12. Sun XH, Copeland NG, Jenkins NA, Baltimore D: Id proteins Id1 and Id2 selectively inhibit DNA binding by one class of helix-loop-helix proteins. Mol Cell Biol 1991, 11:5603-5611.
13. Hara E, Yamaguchi T, Nojima H, Ide T, Campisi J, Okayama H, Oda K: Id-related genes encoding helix-loop-helix proteins are required for G1 progression and are repressed in senescent human fibroblasts. J Biol Chem 1994, 269:2139-2145.
14. Sun XH: Constitutive expression of the Id1 gene impairs mouse B cell development. Cell 1994, 79:893-900.
15. Ohtani N, Zebedee Z, Huot TJ, Stinson JA, Sugimoto M, Ohashi Y, Sharrocks AD, Peters G, Hara E: Opposing effects of Ets and Id proteins on p16INK4a expression during cellular senescence. Nature 2001, 409:1067-1070.
16. Bjorntorp E, Parsa R, Thornemo M, Wennberg AM, Lindahl A: The helix-loop-helix transcription factor Id1 is highly expressed in psoriatic involved skin. Acta Derm Venereol 2003, 83:403-409.
17. Strait KA, Dabbas B, Hammond EH, Warnick CT, Iistrup SJ, Ford CD: Cell cycle blockade and differentiation of ovarian cancer cells by the histone deacetylase inhibitor trichostatin A are associated with changes in p21, Rb, and Id proteins. Mol Cancer Ther 2002, 1:1181-1190.
18. Ezura Y, Tournay O, Nifuji A, Noda M: Identification of a novel suppressive vitamin D response sequence in the 5′-flanking region of the murine Id1 gene. J Biol Chem 1997, 272:29865-29872.
19. Tournay O, Benezra R: Transcription of the dominant-negative helix-loop-helix protein Id1 is regulated by a protein complex containing the immediate-early response gene Egr-1. Mol Cell Biol 1996, 16:2418-2430.
20. Liu C, Yao J, de Belle I, Huang RP, Adamson E, Mercola D: The transcription factor EGR-1 suppresses transformation of human fibrosarcoma HT1080 cells by coordinated induction of transforming growth factor-beta1, fibronectin, and plasminogen activator inhibitor-1. J Biol Chem 1999, 274:4400-4411.
21. Ellisen LW, Ramsayer KD, Johannessen CM, Yang A, Beppu H, Minda K, Oliner JD, McKeon F, Haber DA: REDD1, a developmentally regulated transcriptional target of p63 and p53, links p63 to regulation of reactive oxygen species. Mol Cell 2002, 10:995-1005.
22. Suminami Y, Nagashima S, Murakami A, Nawata S, Gondo T, Hirakawa H, Numa F, Silverman GA, Kato H: Suppression of a squamous cell carcinoma (SCC)-related serpin, SCC antigen, inhibits tumor growth with increased intratumor infiltration of natural killer cells. Cancer Res 2001, 61:1776-1780.
23. Chen Y, Riley DJ, Chen PL, Lee WH: HEC, a novel nuclear protein rich in leucine heptad repeats specifically involved in mitosis. Mol Cell Biol 1997, 17:6049-6056.
24. Semprini S, Capon F, Tacconelli A, Giardina E, Orecchia A, Mingarelli R, Gobello T, Zambruno G, Botta A, Fabrizi G, Novelli G: Evidence for differential S100 gene over-expression in psoriatic patients from genetically heterogeneous pedigrees. Hum Genet 2002, 111:310-313.
25. Yousef GM, Diamandis EP: Tissue kallikreins: new players in normal and abnormal cell growth? Thromb Haemost 2003, 90:7-16.
26. Talieri M, Diamandis EP, Gourgiotis D, Mathioudaki K, Scorilas A: Expression analysis of the human kallikrein 7 (KLK7) in breast tumors: a new potential biomarker for prognosis of breast carcinoma. Thromb Haemost 2004, 91:180-186.
27. McGowan CH, Russell P: Human Wee1 kinase inhibits cell division by phosphorylating p34cdc2 exclusively on Tyr15. Embo J 1993, 12:75-85.
28. Sonoyama K, Rutatip S, Kasai T: Gene expression of activin, activin receptors, and follistatin in intestinal epithelial cells. Am J Physiol Gastrointest Liver Physiol 2000, 278:G89-97.
29. Chen YG, Lui HM, Lin SL, Lee JM, Ying SY: Regulation of cell proliferation, apoptosis, and carcinogenesis by activin. Exp Biol Med (Maywood) 2002, 227:75-87.
30. Murata M, Eto Y, Shibai H, Sakai M, Muramatsu M: Erythroid differentiation factor is encoded by the same mRNA as that of the inhibin beta A chain. Proc Natl Acad Sci U S A 1988, 85:2434-2438.
31. Lin L, Miller CT, Contreras JI, Prescott MS, Dagenais SL, Wu R, Yee J, Orringer MB, Misek DE, Hanash SM, et al.: The hepatocyte nuclear factor 3 alpha gene, HNF3alpha (FOXA1), on chromosome band 14q13 is amplified and overexpressed in esophageal and lung adenocarcinomas. Cancer Res 2002, 62:5273-5279.
32. Horuk R, Yansura DG, Reilly D, Spencer S, Bourell J, Henzel W, Rice G, Unemori E: Purification, receptor binding analysis, and biological characterization of human melanoma growth stimulating activity (MGSA). Evidence for a novel MGSA receptor. J Biol Chem 1993, 268:541-546.
33. Holmes WE, Sliwkowski MX, Akita RW, Henzel WJ, Lee J, Park JW, Yansura D, Abadi N, Raab H, Lewis GD, et al.: Identification of heregulin, a specific activator of p185erbB2. Science 1992, 256:1205-1210.
34. Yan Z, DeGregori J, Shohet R, Leone G, Stillman B, Nevins JR, Williams RS: Cdc6 is regulated by E2F and is essential for DNA replication in mammalian cells. Proc Natl Acad Sci U S A 1998, 95:3603-3608.
35. Grdina DJ, Murley JS, Roberts JC: Effects of thiols on topoisomerase-II alpha activity and cell cycle progression. Cell Prolif 1998, 31:217-229.
36. Mondal N, Parvin JD: DNA topoisomerase IIalpha is required for RNA polymerase II transcription on chromatin templates. Nature 2001, 413:435-438.
37. Fesus L, Piacentini M: Transglutaminase 2: an enigmatic enzyme with diverse functions. Trends Biochem Sci 2002, 27:534-539.
38. Mishra S, Murphy LJ: Tissue transglutaminase has intrinsic kinase activity: Identification of transglutaminase 2 as an insulin-like growth factor binding protein-3 kinase. J Biol Chem 2004, 279(23):23863-8.
39. Ricort JM, Binoux M: Insulin-like growth factor-binding protein- 3 activates a phosphotyrosine phosphatase. Effects on the insulin-like growth factor signaling pathway. J Biol Chem 2002, 277:19448-19454.
40. Perez-Nadales E, Lloyd AC: Essential function for ErbB3 in breast cancer proliferation. Breast Cancer Res 2004, 6:137-139.
41. Ray JM, Stetler-Stevenson WG: The role of matrix metalloproteases and their inhibitors in tumour invasion, metastasis and angiogenesis. Eur Respir J 1994, 7:2062-2072.
42. Coussens LM, Werb Z: Matrix metalloproteinases and the development of cancer. Chem Biol 1996, 3:895-904.
43. Cai T, Fassina G, Morini M, Aluigi MG, Masiello L, Fontanini G, D'Agostini F, De Flora S, Noonan DM, Albini A: N-acetylcysteine inhibits endothelial cell invasion and angiogenesis. Lab Invest 1999, 79:1151-1159.
44. Mashimo H, Wu DC, Podolsky DK, Fishman MC: Impaired defense of intestinal mucosa in mice lacking intestinal trefoil factor. Science 1996, 274:262-265.
45. Agre P, Brown D, Nielsen S: Aquaporin water channels: unanswered questions and unresolved controversies. Curr Opin Cell Biol 1995, 7:472-483.
46. Delporte C, Chen ZJ, Baum BJ: Aquaporin 1 expression during the cell cycle in A5 cells. Biochem Biophys Res Commun 1996, 228:223-228.
47. Matsuzaki T, Suzuki T, Koyama H, Tanaka S, Takata K: Water channel protein AQP3 is present in epithelia exposed to the environment of possible water loss. J Histochem Cytochem 1999, 47:1275-1286.
48. Koyama Y, Yamamoto T, Tani T, Nihei K, Kondo D, Funaki H, Yaoita E, Kawasaki K, Sato N, Hatakeyama K, Kihara I: Expression and localization of aquaporins in rat gastrointestinal tract. Am J Physiol 1999, 276:C621-627.
49. Zheng X, Bollinger Bollag W: Aquaporin 3 colocates with phospholipase d2 in caveolin-rich membrane microdomains and is downregulated upon keratinocyte differentiation. J Invest Dermatol 2003, 121:1487-1495.
50. Heinen CD, Goss KH, Cornelius JR, Babcock GF, Knudsen ES, Kowalik T, Groden J: The APC tumor suppressor controls entry into S-phase through its ability to regulate the cyclin D/RB pathway. Gastroenterology 2002, 123:751-763.
51. Wei Y, Renard CA, Labalette C, Wu Y, Levy L, Neuveut C, Prieur X, Flajolet M, Prigent S, Buendia MA: Identification of the LIM protein FHL2 as a coactivator of beta-catenin. J Biol Chem 2003, 278:5188-5194.
52. Bernard DJ, Chapman SC, Woodruff TK: Mechanisms of inhibin signal transduction. Recent Prog Horm Res 2001, 56:417-450.
53. Hallahan AR, Pritchard JI, Chandraratna RA, Ellenbogen RG, Geyer JR, Overland RP, Strand AD, Tapscott SJ, Olson JM: BMP-2 mediates retinoid-induced apoptosis in medulloblastoma cells through a paracrine effect. Nat Med 2003, 9:1033-1038.
54. Wen XZ, Miyake S, Akiyama Y, Yuasa Y: BMP-2 modulates the proliferation and differentiation of normal and cancerous gastric cells. Biochem Biophys Res Commun 2004, 316:100-106.
55. Langenfeld EM, Calvano SE, Abou-Nukta F, Lowry SF, Amenta P, Langenfeld J: The mature bone morphogenetic protein-2 is aberrantly expressed in non-small cell lung carcinomas and stimulates tumor growth of A549 cells. Carcinogenesis 2003, 24:1445-1454.
56. Hannon GJ, Beach D: p15INK4B is a potential effector of TGF-beta-induced cell cycle arrest. Nature 1994, 371:257-261.
57. Lee MH, Reynisdottir I, Massague J: Cloning of p57KIP2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution. Genes Dev 1995, 9:639-649.
58. Jacobs-Helber SM, Abutin RM, Tian C, Bondurant M, Wickrema A, Sawyer ST: Role of JunB in erythroid differentiation. J Biol Chem 2002, 277:4859-4866.
59. Passegue E, Jochum W, Schorpp-Kistner M, Mohle-Steinlein U, Wagner EF: Chronic myeloid leukemia with increased granulocyte progenitors in mice lacking junB expression in the myeloid lineage. Cell 2001, 104:21-32.
60. Rouault JP, Rimokh R, Tessa C, Paranhos G, Ffrench M, Duret L, Garoccio M, Germain D, Samarut J, Magaud JP: BTG1, a member of a new family of antiproliferative genes. Embo J 1992, 11:1663-1670.
61. Lee SW: H-cadherin, a novel cadherin with growth inhibitory functions and diminished expression in human breast cancer. Nat Med 1996, 2:776-782.
62. van Belzen N, Dinjens WN, Diesveld MP, Groen NA, van der Made AC, Nozawa Y, Vlietstra R, Trapman J, Bosman FT: A novel gene which is up-regulated during colon epithelial cell differentiation and down-regulated in colorectal neoplasms. Lab Invest 1997, 77:85-92.
63. Aoki K, Tamai Y, Horiike S, Oshima M, Taketo MM: Colonic polyposis caused by mTOR-mediated chromosomal instability in Apc+/Delta716 Cdx2+/- compound mutant mice. Nat Genet 2003, 35:323-330.
64. Shepherd TG, Nachtigal MW: Identification of a putative autocrine bone morphogenetic protein-signaling pathway in human ovarian surface epithelium and ovarian cancer cells. Endocrinology 2003, 144:3306-3314.
65. Langenfeld EM, Langenfeld J: Bone morphogenetic protein-2 stimulates angiogenesis in developing tumors. Mol Cancer Res 2004, 2:141-149.
66. Tsujii M, Kawano S, DuBois RN: Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential. Proc Natl Acad Sci U S A 1997, 94:3336-3340.
67. Tsujii M, Kawano S, Tsuji S, Sawaoka H, Hori M, DuBois RN: Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell 1998, 93:705-716.
68. Neufang G, Furstenberger G, Heidt M, Marks F, Muller-Decker K: Abnormal differentiation of epidermis in transgenic mice constitutively expressing cyclooxygenase-2 in skin. Proc Natl Acad Sci U S A 2001, 98:7629-7634.
69. Chinery R, Beauchamp RD, Shyr Y, Kirkland SC, Coffey RJ, Morrow JD: Antioxidants reduce cyclooxygenase-2 expression, prostaglandin production, and proliferation in colorectal cancer cells. Cancer Res 1998, 58:2323-2327.
70. Lavender P, Vandel L, Bannister AJ, Kouzarides T: The HMG-box transcription factor HBP1 is targeted by the pocket proteins and E1A. Oncogene 1997, 14:2721-2728.
71. Tevosian SG, Shih HH, Mendelson KG, Sheppard KA, Paulson KE, Yee AS: HBP1: a HMG box transcriptional repressor that is targeted by the retinoblastoma family. Genes Dev 1997, 11:383-396.
72. Sampson EM, Haque ZK, Ku MC, Tevosian SG, Albanese C, Pestell RG, Paulson KE, Yee AS: Negative regulation of the Wnt-beta-catenin pathway by the transcriptional repressor HBP1. Embo J 2001, 20:4500-4511.
73. Zhang L, Zhou W, Velculescu VE, Kern SE, Hruban RH, Hamilton SR, Vogelstein B, Kinzler KW: Gene expression profiles in normal and cancer cells. Science 1997, 276:1268-1272.
74. Vachon PH, Beaulieu JF: Transient mosaic patterns of morphological and functional differentiation in the Caco-2 cell line. Gastroenterology 1992, 103:414-423.
75. Wang H, Chakrabarty S: Platelet-activating factor activates mitogen-activated protein kinases, inhibits proliferation, induces differentiation and suppresses the malignant phenotype of human colon carcinoma cells. Oncogene 2003, 22:2186-2191.
76. Shimada A, Ota Y, Sugiyama Y, Sato S, Kume K, Shimizu T, Inoue S: In situ expression of platelet-activating factor (PAF)-receptor gene in rat skin and effects of PAF on proliferation and differentiation of cultured human keratinocytes. J Invest Dermatol 1998, 110:889-893.